Studies have shown that the standard advanced cardiac life support (ACLS) drug regimen that includes vasopressin improves survival after cardiac arrest. But does vasopressin really make a difference?

Axcelis Technologies (ACLS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ACLS broke through the 20-day moving average, which ...

Axcelis Technologies, Inc. (NASDAQ:ACLS) engages in the design, manufacturing, and servicing of ion implantation and other processing equipment used in the fabrication of semiconductor chips.

Fintel reports that on April 21, 2025, B. Riley Securities downgraded their outlook for Axcelis Technologies (NasdaqGS:ACLS) from Buy to Neutral. Analyst Price Forecast Suggests 110.73% Upside As ...

Routine drugs are not recommended for ACLS, said Berg. Epinephrine at a fixed dose can be used early, but it is most beneficial in patients with unshockable rhythms, he said.

Epinephrine was the first line recommendation for anaphylaxis in 97% (29) of protocols. 25 states (83%) allowed epinephrine autoinjectors and 17 (57%) provided autoinjectors.

Notable Friday Option Activity: GNL, ACLS, LENZ May 02, 2025 — 03:22 pm EDT Written by BNK Invest for BNK Invest -> ...

Axcelis (ACLS) delivered earnings and revenue surprises of 166.67% and 4.29%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?